- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Medical Home Fails to Prove Quality, Cost Claims
Although highly touted, the patient-centered medical home model failed to lower use of services or total costs and produced little quality improvement over three years, research has found.
Although highly touted, the patient-centered medical home model failed to lower use of services or total costs and produced little quality improvement over three years, research in the latest Journal of the American Medical Association (JAMA) has found.
However, a number of factors may account for the findings and suggest that medical homes may need “further refinement.”
The research tracked the southeastern Pennsylvania Chronic Care Initiative in one of the first, largest and longest-running multi-payer trials of the team-based model from 2008 to 2011. The pilot included 32 primary care practices with recognition from the National Committee for Quality Assurance (NCQA) and six health plans, with two commercial and two Medicaid plans supplying claims data.
Medical home efforts have encouraged primary providers to invest in patient registries, use electronic medication prescribing, enhanced access options and other structural changes aimed at improving patient care in exchange for bonuses.
Read the full story here: http://bit.ly/NCReps
Source: Healthcare Payer News
Care Quality Metrics in Medicare During COVID-19 Pandemic
August 12th 2025Medicare Advantage outperformed traditional Medicare on clinical quality measures before and during the COVID-19 pandemic; mid-pandemic, however, traditional Medicare narrowed the gap on some in-person screenings.
Read More
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
